CRDL - Cardiol Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

CRDL is currently covered by 2 analysts with an average price target of $9.5. This is a potential upside of $8.64 (1004.65%) from yesterday's end of day stock price of $0.86.

Our record on CRDL covers 5 analysts since 2008; 2 cover it today. Of the 18 price targets those analysts set on CRDL, 0 were reached (0%). The highest performance score on CRDL belongs to Brandon Folkes of H.C. Wainwright: 0.00, with 0 of 5 targets met. The latest calls: Brandon Folkes of H.C. Wainwright kept the target at $9 with a Buy rating on 23 Sep 2026; Edward Nash of Canaccord raised the target to $10 from $8 with a Buy rating on 17 Aug 2026; Vernon Bernardino of H.C. Wainwright updated the call with a Buy rating on 16 Apr 2025. Figures as of 18 Nov 2026.

Cardiol Therapeutics's activity chart (see below) currently has 16 price targets and 29 ratings on display. The stock rating distribution of CRDL is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for CRDL is $10, Lowest price target is $9, average price target is $9.5.

Most recent stock forecast was given by BRANDON FOLKES from HC WAINWRIGHT on 23-Sep-2026. First documented stock forecast 03-Dec-2021.

Best performing analysts who are covering CRDL - Cardiol Therapeutics:

Edward Nash Charles Duncan Vernon Bernardino Brandon Folkes

Currently out of the existing stock ratings of CRDL, 6 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 28-Jan-2025

$9

$8 (800.00%)

$9

1 months 30 days ago
(23-Sep-2026)

0/5 (0%)

$7.23 (408.47%)

Buy Since 03-Dec-2021

$10

$9 (900.00%)

$8

3 months 5 days ago
(17-Aug-2026)

0/6 (0%)

$8.2 (455.56%)

Buy Since 14-May-2024

1 years 7 months 6 days ago
(16-Apr-2025)

0/4 (0%)

$7.12 (378.72%)

Buy Since 17-Dec-2021

$3

$4

3 years 3 months 8 days ago
(14-Aug-2023)

0/3 (0%)

$2.07 (222.58%)

Show more analysts

Please expand the browser size to see the chart

Which analyst most recently updated their price target on CRDL (Cardiol Therapeutics)?

Brandon Folkes

Which analyst has the lowest performance score on CRDL (Cardiol Therapeutics) with a proven track record?

BRANDON FOLKES

Which analyst has the most public recommendations on CRDL (Cardiol Therapeutics)?

Brandon Folkes works at HC WAINWRIGHT and has 7 price targets and 5 ratings on CRDL

Which analyst is the currently most bullish on CRDL (Cardiol Therapeutics)?

Edward Nash with the highest potential upside of $9

Which analyst is the currently most reserved on CRDL (Cardiol Therapeutics)?

Vernon Bernardino with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?